Crystec announces new strategic partnership with Joel Hi-Tech
10 Mar 2026
Bradford, UK – Crystec Limited (CrystecPharma) is delighted to announce a strategic partnership with Joel Hi-Tech, China’s leading supercritical fluid extraction technology company. By combining Joel Hi-Tech’s industrial-scale supercritical extraction capabilities with Crystec’s advanced particle engineering expertise, the collaboration significantly expands opportunities to develop high-quality, scalable, and differentiated natural product-based medicines.
Qun Shao, Chief Operating Officer at CrystecPharma, commented:
“This partnership is a natural fit for CrystecPharma. SFE Joel Hi-Tech’s considerable expertise in supercritical extraction complements our particle engineering capabilities, enabling the development of uniform, natural product medicines of exceptional quality.”
Weixiang Zhao, CEO at Joel Hi-Tech, added:
“We are excited to partner with CrystecPharma. By combining our expertise in supercritical extraction technology with their deep pharmaceutical insight, this collaboration reflects our shared commitment to innovation and sustainable process solutions. We look forward to advancing the development of natural product-based medicines together.”
About CrystecPharma (www.crystecpharma.com):
CrystecPharma, established in 2007, is a crystal and particle engineering company which applies its proprietary mSAS® (modified Supercritical Anti-Solvent) drug formulation technology to improve the performance of medicines. The technique allows many molecules that are traditionally challenging to formulate to be developed as high-performing powders. CrystecPharma’ unique equipment configuration means formulation and process development can occur in a matter of weeks.
About Joel Hi-Tech (http://www.joel.cn):
Joel Hi-Tech is a leading enterprise in China's supercritical fluid technology sector. As the first professional team in the country dedicated to the research and development of supercritical fluid technology and complete equipment solution, it successfully developed China's first set of laboratory-scale, pilot-scale, and industrial-scale supercritical fluid extraction equipment.
Since 1986, the company has focused on the development of supercritical fluid extraction processes and complete engineering solutions for obtaining active ingredients from natural products. This technology efficiently extracts functional components from natural products under mild, near-body-temperature conditions. Compared to traditional methods, it boosts production efficiency, yields richer extracts, and better preserves active ingredients by preventing thermal degradation.
Editor Details
-
Company:
- CrystecPharma
-
Name:
- Joseph Brear
- Email:
-
Telephone:
- +447467369025
- Website:
Related Links
- Website: Crystec new strategic partnership